See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Dec. 13, 2006

Eye Disorders/Infections Diabetes - Type 2 Rheumatoid Arthritis

(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:

Eye Disorders/Infections

This clinical research study will evaluate the safety and effectiveness of an investigational drug eye drop in people with pink eye. Pink eye symptoms may include eye redness, crusty and sticky eyes, yellow or green discharge, watery, irritated eyes, or eye swelling. This study involves three visits over approximately eight days, and patients will receive compensation for participation.

The research site is in Paramount, Calif.

More information

Please see


Diabetes - Type 2

This is a research study of an investigational drug for type 2 diabetes. The study will last about 14 weeks and will require about four visits. Volunteers 18-80 who have type 2 diabetes currently treated with only metformin (Glucophage) and are otherwise generally healthy may qualify.

The research site is in Longmont, Col.

More information

Please see


Rheumatoid Arthritis

This study will evaluate the effectiveness of an investigational medication in controlling the signs and symptoms of rheumatoid arthritis when taken in addition to methotrexate. Candidates at least 18 who have active rheumatoid arthritis, are taking 10 mg to 25 mg of methotrexate per week, and have at least six tender joints and at least six swollen joints may qualify.

The research sites are located across the United States.

More information

Please see


Copyright 2006 Thomson CenterWatch. All rights reserved.

Consumer News


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.